Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hemispherx Hasn't Called FDA on Ampligen Review
TheStreet.com
Monday, September 14, 2009 - 9:00am
tags:
FDA, Hemispherx, chronic fatigue syndrome, Ampligen, Amag Pharmaceuticals
Breast Cancer Gene Testing for Roche’s Herceptin Often Lacking
Bloomberg
Monday, September 14, 2009 - 8:57am
tags:
Roche, Herceptin, breast cancer
Teva shares off; Mylan files for generic Copaxone
Marketwatch
Monday, September 14, 2009 - 8:27am
tags:
Teva Pharmaceuticals, generics, Mylan, Copaxone
Swine Flu Expectation Game
The Street
Sunday, September 13, 2009 - 1:33pm
tags:
swine flu
Readers Ask: Antares, GenVec, Xoma
Seeking Alpha
Sunday, September 13, 2009 - 1:31pm
tags:
Antares, GenVec, Xoma
ChinaBio Day Unveils Program Highlights
PharmaLive
Sunday, September 13, 2009 - 12:56pm
tags:
ChinaBio
Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
Sunday, September 13, 2009 - 12:53pm
tags:
Teva Pharmaceuticals
Teva: MS drug Laquinimod works two ways
Globes, Israel
Sunday, September 13, 2009 - 12:51pm
tags:
laquinimod, Teva Pharmaceuticals, MS, multiple sclerosis
Spectrum Pharma: Market Opportunities for Zevalin May Expand Significantly
Seeking Alpha
Sunday, September 13, 2009 - 12:45pm
tags:
Zevalin, Spectrum Pharmaceuticals
Biotech Busy with Bevy of Small Deals
Seeking Alpha
Sunday, September 13, 2009 - 12:34pm
tags:
biotech
Isis Pharma to get expanded US patent for single-stranded RNAi technology
Pharmabiz
Saturday, September 12, 2009 - 10:38am
tags:
Isis Pharmaceuticals
Salix Gets FDA Marketing OK for Metozolv ODT
Trading Markets
Saturday, September 12, 2009 - 10:37am
tags:
Salix, Metozolv
Analyst Lists Five Biotech Companies to Watch
Patent Docs
Saturday, September 12, 2009 - 10:35am
tags:
Poniard, GTx, OncoGenex, MannKind, Rigel
Theravance and Astellas Announce FDA Approval of VIBATIV(TM) (telavancin) for the Treatment of Complicated Skin and Skin Structure Infections
MarketWire
Saturday, September 12, 2009 - 10:31am
tags:
Theravance, Astellas, Vibativ
3 Hot Biotech Bets, Right Now!
CNBC
Saturday, September 12, 2009 - 10:29am
tags:
Genzyme, Gilead Sciences, Amgen
Osiris CFO leaves after failure of stem-cell drug
Yahoo/AP
Saturday, September 12, 2009 - 10:19am
tags:
Osiris, stem cells
Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
PR NewsWire
Saturday, September 12, 2009 - 10:18am
tags:
Regeneron, Aflibercept, pancreatic cancer
Merck gains on Fosamax ruling
MarketWatch
Saturday, September 12, 2009 - 10:17am
tags:
Merck, Fosamax
Judge declares mistrial in first Fosamax trial
Yahoo/AP
Saturday, September 12, 2009 - 10:15am
tags:
Fosamax, Merck
Nycomed Said to Be Close to Getting Debt Funding for Solvay Bid
Bloomberg
Friday, September 11, 2009 - 9:23am
tags:
Nycomed, Solvay, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.